Clinical trials
Recruiting Amyloidosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University First Hospital | 2 |
| Tianjin Medical University | 2 |
| Alnylam Pharmaceuticals | 1 |
| AstraZeneca | 1 |
| Gracell Biotechnologies (Shanghai) Co., Ltd. | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Nanjing University School of Medicine | 1 |
| Sinocelltech Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amyloidosis | 10 |
| Amyloid Neuropathies, Familial | 3 |
| Immunoglobulin Light-chain Amyloidosis | 3 |
| Alzheimer Disease | 2 |
| Amyloid Neuropathies | 1 |
| Amyloidosis, Familial | 1 |
| Arthritis, Rheumatoid | 1 |
| Cardiomyopathies | 1 |
| Cardiovascular Diseases | 1 |
| Castleman Disease | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.